Semper Paratus Acquisition Corporation Files Registration Statement on Form S-4 in Connection with Proposed Business Combination with Tevogen Bio Inc
The Registration Statement contains a preliminary proxy statement and prospectus in connection with the previously announced agreement and plan of merger (the “Merger Agreement”) and proposed business combination between Semper Paratus and Tevogen Bio (the “Transaction”).
- The Registration Statement contains a preliminary proxy statement and prospectus in connection with the previously announced agreement and plan of merger (the “Merger Agreement”) and proposed business combination between Semper Paratus and Tevogen Bio (the “Transaction”).
- While the Registration Statement has not yet become effective and the information contained therein is subject to change, it provides important information about Tevogen Bio, Semper Paratus, and the Transaction.
- Upon closing of the Transaction, the combined company will be named Tevogen Bio Holdings Inc. (“Tevogen Holdings”).
- Tevogen Bio aspires to be the first biotechnology company offering commercially attractive, economically viable, and cost-effective personalized T cell therapies.